메뉴 건너뛰기




Volumn 28, Issue 1, 2009, Pages 187-194

Whole recombinant Hansenula polymorpha expressing hepatitis B virus surface antigen (yeast-HBsAg) induces potent HBsAg-specific Th1 and Th2 immune responses

Author keywords

H. polymorpha; HBV vaccine; Th1 immune responses

Indexed keywords

ALUMINUM POTASSIUM SULFATE; FUNGUS VECTOR; GAMMA INTERFERON; HEPATITIS B SURFACE ANTIGEN; HEPATITIS VACCINE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; INTERLEUKIN 4; MOLECULAR THERAPY AGENT; UNCLASSIFIED DRUG;

EID: 70649115445     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.09.101     Document Type: Article
Times cited : (28)

References (26)
  • 1
    • 33748301260 scopus 로고    scopus 로고
    • Global challenges in liver disease
    • Williams R. Global challenges in liver disease. Hepatology 44 3 (2006) 521-526
    • (2006) Hepatology , vol.44 , Issue.3 , pp. 521-526
    • Williams, R.1
  • 2
    • 0642374132 scopus 로고    scopus 로고
    • Resistance of HBV to adefovir dipivoxil: a case for combination antiviral therapy?
    • Aloman C., and Wands J.R. Resistance of HBV to adefovir dipivoxil: a case for combination antiviral therapy?. Hepatology 38 6 (2003) 1584-1587
    • (2003) Hepatology , vol.38 , Issue.6 , pp. 1584-1587
    • Aloman, C.1    Wands, J.R.2
  • 4
    • 0034494840 scopus 로고    scopus 로고
    • Meta-analysis of published clinical trials of a ribosomal vaccine (ribomunyl ((r))) in prevention of respiratory infections
    • Boyle P., Bellanti J.A., and Robertson C. Meta-analysis of published clinical trials of a ribosomal vaccine (ribomunyl ((r))) in prevention of respiratory infections. Biodrugs 14 6 (2000) 389-408
    • (2000) Biodrugs , vol.14 , Issue.6 , pp. 389-408
    • Boyle, P.1    Bellanti, J.A.2    Robertson, C.3
  • 5
    • 24944567410 scopus 로고    scopus 로고
    • Augmented humoral and cellular immune responses to hepatitis B DNA vaccine adsorbed onto cationic microparticles
    • He X., Jiang L., Wang F., Xiao Z., Li J., Liu L.S., et al. Augmented humoral and cellular immune responses to hepatitis B DNA vaccine adsorbed onto cationic microparticles. J Control Release 107 2 (2005) 357-372
    • (2005) J Control Release , vol.107 , Issue.2 , pp. 357-372
    • He, X.1    Jiang, L.2    Wang, F.3    Xiao, Z.4    Li, J.5    Liu, L.S.6
  • 7
    • 0035925668 scopus 로고    scopus 로고
    • Immunotherapy of chronic hepatitis B by anti-HBV vaccine: from present to future
    • Michel M.L., Pol S., Brechot C., and Tiollais P. Immunotherapy of chronic hepatitis B by anti-HBV vaccine: from present to future. Vaccine 19 17-19 (2001) 2395-2399
    • (2001) Vaccine , vol.19 , Issue.17-19 , pp. 2395-2399
    • Michel, M.L.1    Pol, S.2    Brechot, C.3    Tiollais, P.4
  • 8
    • 0032546352 scopus 로고    scopus 로고
    • Dendritic cells and the control of immunity
    • Banchereau J., and Steinman R.M. Dendritic cells and the control of immunity. Nature 392 6673 (1998) 245-252
    • (1998) Nature , vol.392 , Issue.6673 , pp. 245-252
    • Banchereau, J.1    Steinman, R.M.2
  • 10
    • 0024353079 scopus 로고
    • TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties
    • Mosmann T.R., and Coffman R.L. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 7 (1989) 145-173
    • (1989) Annu Rev Immunol , vol.7 , pp. 145-173
    • Mosmann, T.R.1    Coffman, R.L.2
  • 11
    • 0035031781 scopus 로고    scopus 로고
    • Whole recombinant yeast vaccine activates dendritic cells and elicits protective cell-mediated immunity
    • Stubbs A.C., Martin K.S., Coeshott C., Skaates S.V., Kuritzkes D.R., Bellgrau D., et al. Whole recombinant yeast vaccine activates dendritic cells and elicits protective cell-mediated immunity. Nat Med 7 5 (2001) 625-629
    • (2001) Nat Med , vol.7 , Issue.5 , pp. 625-629
    • Stubbs, A.C.1    Martin, K.S.2    Coeshott, C.3    Skaates, S.V.4    Kuritzkes, D.R.5    Bellgrau, D.6
  • 13
    • 48249091314 scopus 로고    scopus 로고
    • Vaccination with a recombinant Saccharomyces cerevisiae expressing a tumor antigen breaks immune tolerance and elicits therapeutic antitumor responses
    • Wansley E.K., Chakraborty M., Hance K.W., Bernstein M.B., Boehm A.L., Guo Z., et al. Vaccination with a recombinant Saccharomyces cerevisiae expressing a tumor antigen breaks immune tolerance and elicits therapeutic antitumor responses. Clin Cancer Res 14 13 (2008) 4316-4325
    • (2008) Clin Cancer Res , vol.14 , Issue.13 , pp. 4316-4325
    • Wansley, E.K.1    Chakraborty, M.2    Hance, K.W.3    Bernstein, M.B.4    Boehm, A.L.5    Guo, Z.6
  • 14
    • 37849035624 scopus 로고    scopus 로고
    • Recombinant Saccharomyces cerevisiae (yeast-CEA) as a potent activator of murine dendritic cells
    • Bernstein M.B., Chakraborty M., Wansley E.K., Guo Z., Franzusoff A., Mostbock S., et al. Recombinant Saccharomyces cerevisiae (yeast-CEA) as a potent activator of murine dendritic cells. Vaccine 26 4 (2008) 509-521
    • (2008) Vaccine , vol.26 , Issue.4 , pp. 509-521
    • Bernstein, M.B.1    Chakraborty, M.2    Wansley, E.K.3    Guo, Z.4    Franzusoff, A.5    Mostbock, S.6
  • 15
    • 0036079796 scopus 로고    scopus 로고
    • Recombinant yeast as a vaccine vector for the induction of cytotoxic T-lymphocyte responses
    • Stubbs A.C., and Wilson C.C. Recombinant yeast as a vaccine vector for the induction of cytotoxic T-lymphocyte responses. Curr Opin Mol Ther 4 1 (2002) 35-40
    • (2002) Curr Opin Mol Ther , vol.4 , Issue.1 , pp. 35-40
    • Stubbs, A.C.1    Wilson, C.C.2
  • 16
    • 33846088350 scopus 로고    scopus 로고
    • Whole recombinant yeast-based immunotherapy induces potent T cell responses targeting HCV NS3 and Core proteins
    • Haller A.A., Lauer G.M., King T.H., Kemmler C., Fiolkoski V., Lu Y., et al. Whole recombinant yeast-based immunotherapy induces potent T cell responses targeting HCV NS3 and Core proteins. Vaccine 25 8 (2007) 1452-1463
    • (2007) Vaccine , vol.25 , Issue.8 , pp. 1452-1463
    • Haller, A.A.1    Lauer, G.M.2    King, T.H.3    Kemmler, C.4    Fiolkoski, V.5    Lu, Y.6
  • 17
    • 27644574423 scopus 로고    scopus 로고
    • New yeast expression platforms based on methylotrophic Hansenula polymorpha and Pichia pastoris and on dimorphic Arxula adeninivorans and Yarrowia lipolytica-a comparison
    • Gellissen G., Kunze G., Gaillardin C., Cregg J.M., Berardi E., Veenhuis M., et al. New yeast expression platforms based on methylotrophic Hansenula polymorpha and Pichia pastoris and on dimorphic Arxula adeninivorans and Yarrowia lipolytica-a comparison. FEMS Yeast Res 5 11 (2005) 1079-1096
    • (2005) FEMS Yeast Res , vol.5 , Issue.11 , pp. 1079-1096
    • Gellissen, G.1    Kunze, G.2    Gaillardin, C.3    Cregg, J.M.4    Berardi, E.5    Veenhuis, M.6
  • 18
    • 47149115664 scopus 로고    scopus 로고
    • Analysis and characterization of hepatitis B vaccine particles synthesized from Hansenula polymorpha
    • Seo H.S., Park J.S., Han K.Y., Bae K.D., Ahn S.J., Kang H.A., et al. Analysis and characterization of hepatitis B vaccine particles synthesized from Hansenula polymorpha. Vaccine 26 33 (2008) 4138-4144
    • (2008) Vaccine , vol.26 , Issue.33 , pp. 4138-4144
    • Seo, H.S.1    Park, J.S.2    Han, K.Y.3    Bae, K.D.4    Ahn, S.J.5    Kang, H.A.6
  • 20
    • 0030903829 scopus 로고    scopus 로고
    • Comparison between hepatitis B surface antigen (HBsAg) particles derived from mammalian cells (CHO) and yeast cells (Hansenula polymorpha) composition, structure and immunogenicity
    • Diminsky D., Schirmbeck R., Reimann J., and Barenholz Y. Comparison between hepatitis B surface antigen (HBsAg) particles derived from mammalian cells (CHO) and yeast cells (Hansenula polymorpha) composition, structure and immunogenicity. Vaccine 15 6-7 (1997) 637-647
    • (1997) Vaccine , vol.15 , Issue.6-7 , pp. 637-647
    • Diminsky, D.1    Schirmbeck, R.2    Reimann, J.3    Barenholz, Y.4
  • 21
    • 0027935971 scopus 로고
    • CARE-LASS (calcein-release-assay), an improved fluorescence-based test system to measure cytotoxic T lymphocyte activity
    • Lichtenfels R., Biddison W.E., Schulz H., Vogt A.B., and Martin R. CARE-LASS (calcein-release-assay), an improved fluorescence-based test system to measure cytotoxic T lymphocyte activity. J Immunol Methods 172 2 (1994) 227-239
    • (1994) J Immunol Methods , vol.172 , Issue.2 , pp. 227-239
    • Lichtenfels, R.1    Biddison, W.E.2    Schulz, H.3    Vogt, A.B.4    Martin, R.5
  • 22
    • 0035919599 scopus 로고    scopus 로고
    • Therapeutic efficacy of hepatitis B surface antigen-antibodies-recombinant DNA composite in HBsAg transgenic mice
    • Zheng B.J., Ng M.H., He L.F., Yao X., Chan K.W., Yuen K.Y., et al. Therapeutic efficacy of hepatitis B surface antigen-antibodies-recombinant DNA composite in HBsAg transgenic mice. Vaccine 19 30 (2001) 4219-4225
    • (2001) Vaccine , vol.19 , Issue.30 , pp. 4219-4225
    • Zheng, B.J.1    Ng, M.H.2    He, L.F.3    Yao, X.4    Chan, K.W.5    Yuen, K.Y.6
  • 23
    • 0036518287 scopus 로고    scopus 로고
    • Mouse and human dendritic cell subtypes
    • Shortman K., and Liu Y.J. Mouse and human dendritic cell subtypes. Nat Rev Immunol 2 3 (2002) 151-161
    • (2002) Nat Rev Immunol , vol.2 , Issue.3 , pp. 151-161
    • Shortman, K.1    Liu, Y.J.2
  • 24
    • 2142827027 scopus 로고    scopus 로고
    • The primary study on the anti-HBV effect of whole recombinant yeast
    • Zeng Y., Cai D.C., Peng M.L., and Ren H. The primary study on the anti-HBV effect of whole recombinant yeast. Zhonghua Gan Zang Bing Za Zhi 11 12 (2003) 728-730
    • (2003) Zhonghua Gan Zang Bing Za Zhi , vol.11 , Issue.12 , pp. 728-730
    • Zeng, Y.1    Cai, D.C.2    Peng, M.L.3    Ren, H.4
  • 25
    • 0029878805 scopus 로고    scopus 로고
    • Yeast expressing hepatitis B virus surface antigen determinants on its surface: implications for a possible oral vaccine
    • Schreuder M.P., Deen C., Boersma W.J., Pouwels P.H., and Klis F.M. Yeast expressing hepatitis B virus surface antigen determinants on its surface: implications for a possible oral vaccine. Vaccine 14 5 (1996) 383-388
    • (1996) Vaccine , vol.14 , Issue.5 , pp. 383-388
    • Schreuder, M.P.1    Deen, C.2    Boersma, W.J.3    Pouwels, P.H.4    Klis, F.M.5
  • 26
    • 33744808242 scopus 로고    scopus 로고
    • The immune response during hepatitis B virus infection
    • Bertoletti A., and Gehring A.J. The immune response during hepatitis B virus infection. J Gen Virol 87 Pt 6 (2006) 1439-1449
    • (2006) J Gen Virol , vol.87 , Issue.PART 6 , pp. 1439-1449
    • Bertoletti, A.1    Gehring, A.J.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.